Rheumatoid Arthritis

Multisystem Intervention Reduces Missed Opportunities for Influenza Vaccination in RA

Multisystem Intervention Reduces Missed Opportunities for Influenza Vaccination in RA

By

Many patients with rheumatoid arthritis currently experience missed opportunities to be vaccinated against influenza.

RA Associated With Greater Reduction in Short-Term Disease Burden vs Osteoarthritis

RA Associated With Greater Reduction in Short-Term Disease Burden vs Osteoarthritis

By

Investigators analyzed MDHAQ/RAPID3 scores in patients with osteoarthritis or rheumatoid arthritis to assess disease burden associated with each rheumatic disease.

Tofacitinib May Effectively Alleviate Pain in RA, Psoriatic Arthritis, and Ankylosing Spondylitis

Tofacitinib May Effectively Alleviate Pain in RA, Psoriatic Arthritis, and Ankylosing Spondylitis

By

Tofacitinib may provide a fast and prolonged analgesic effect in patients with rheumatoid arthritis or psoriatic arthritis who are unresponsive to csDMARD or to TNFi, as well as in individuals with ankylosing spondylitis.

RA: Psychological State Predicts Disease Flare Following TNF Tapering

RA: Psychological State Predicts Disease Flare Following TNF Tapering

By

Based on these results, clinicians should consider assessing functional and mental health states before biologic tapering.

RA: MRI Values May Not Benefit Clinical, Radiographic Outcomes in Treat-to-Target Strategy

RA: MRI Values May Not Benefit Clinical, Radiographic Outcomes in Treat-to-Target Strategy

By

Researchers sought to determine whether a treat-to-target strategy based on MRI assessments targeting absence bone marrow edema would lead to improved clinical and radiographic outcomes.

Initial High Disease Activity in Rheumatoid Arthritis Linked to Depression

Initial High Disease Activity in Rheumatoid Arthritis Linked to Depression

By

Investigators sought to determine whether initial high disease activity or changes in disease activity contribute to the development of persistent depression among patients with early rheumatoid arthritis.

Upadacitinib Monotherapy Yields Positive Results in Phase 3 Rheumatoid Arthritis Study

Upadacitinib Monotherapy Yields Positive Results in Phase 3 Rheumatoid Arthritis Study

By

Results of the phase 3 SELECT-EARLY study show positive results for upadacitinib in adult patients with moderate to severe rheumatoid arthritis.

RA Treatment Unlikely to Improve Mental Health Outcomes

RA Treatment Unlikely to Improve Mental Health Outcomes

By

Mental health outcomes in patients with RA are unlikely to resolve with effective RA pharmacological disease management alone.

FDA Approves Baricitinib for Adults With Active Rheumatoid Arthritis

FDA Approves Baricitinib for Adults With Active Rheumatoid Arthritis

By

The FDA has approved baricitinib for the treatment of adults with active rheumatoid arthritis who have had an inadequate response to ≥1 tumor necrosis factor antagonist.

Predictors of Post-Chikungunya Chronic Polyarthralgia

Predictors of Post-Chikungunya Chronic Polyarthralgia

By

Researchers reported on the first outbreak of an Asian lineage of chikungunya virus in Aruba.

RA Treatment During Pregnancy: Is Infection Risk Greater in Offspring?

RA Treatment During Pregnancy: Is Infection Risk Greater in Offspring?

By

Children exposed to TNFi's during the gestational period were found not to have a significantly higher risk of developing serious infections.

HBV Status Linked to Disease Activity and Progression in Rheumatoid Arthritis

HBV Status Linked to Disease Activity and Progression in Rheumatoid Arthritis

By

Patients with rheumatoid arthritis with chronic hepatitis B virus infection demonstrated greater radiographic progression and poorer clinical response at 1 year.

Risks Associated With Co-Administration of Aspirin and Other NSAIDs

Risks Associated With Co-Administration of Aspirin and Other NSAIDs

By

In patients with rheumatoid arthritis or osteoarthritis who are at higher risk for cardiovascular events, celecoxib may be safer compared with naproxen or ibuprofen when these drugs are taken alone or in combination with aspirin.

Corticosteroid-Related Adverse Events Examined Based on Dose, Duration

Corticosteroid-Related Adverse Events Examined Based on Dose, Duration

By

Using a privately-insured administrative database, researchers examined a total of 78,704 patients with autoimmune or inflammatory disease diagnoses between 2006 and 2015.

RA: Low Probability of Achieving LDA With Lack of Early Response to Tofacitinib

RA: Low Probability of Achieving LDA With Lack of Early Response to Tofacitinib

By

This study sought to examine the link between early disease activity changes and attainment of LDA and remission targets in tofacitinib-treated patients with RA.

Severe Obesity Linked to Rapid Progression of Disability in Rheumatoid Arthritis

Severe Obesity Linked to Rapid Progression of Disability in Rheumatoid Arthritis

By

Severe obesity is associated with more rapid progression of disability in rheumatoid arthritis.

Patients With Rheumatic Diseases Need to Be Monitored for HBV Reactivation

Patients With Rheumatic Diseases Need to Be Monitored for HBV Reactivation

By

Clinicians need to monitor reactivation of the hepatitis B virus in patients with rheumatic diseases by testing for elevation of liver enzymes and HBV DNA levels.

Temporary Methotrexate Discontinuation in RA: Ensuring Vaccination Immunogenicity

Temporary Methotrexate Discontinuation in RA: Ensuring Vaccination Immunogenicity

By

Rheumatologists should coordinate with the patient's primary care provider to facilitate an effective and comprehensive vaccination schedule.

Incidence of Cardiovascular Events Similar in Rheumatoid Arthritis, Spondyloarthritis

Incidence of Cardiovascular Events Similar in Rheumatoid Arthritis, Spondyloarthritis

By

The incidence of adverse cardiovascular events in patients with RA do not differ significantly compared with those with PsA or axSpA.

Decreased Muscle Performance Linked to Increased Disease Activity in Rheumatoid Arthritis

Decreased Muscle Performance Linked to Increased Disease Activity in Rheumatoid Arthritis

By

Poorer muscle performance composite scores are associated with increased Disease Activity Scores for 28 joints in patients with rheumatoid arthritis.

Effects of Certolizumab Pegol Exposure on Pregnancy Outcomes in Women With Rheumatic Disease

Effects of Certolizumab Pegol Exposure on Pregnancy Outcomes in Women With Rheumatic Disease

By

Researchers sought to provide information on pregnancy outcomes, including major congenital malformations and other maternal and fetal adverse outcomes, in women treated with certolizumab pegol.

FDA Advisory Committee Recommends Against Approval of Baricitinib at Higher Dose for RA

FDA Advisory Committee Recommends Against Approval of Baricitinib at Higher Dose for RA

By

The FDA advisory panel voted in favor of baricitinib for the treatment of rheumatoid arthritis, but only recommended approval of the 2 mg dose.

Precision Medicine in Rheumatology: Personalizing Treatment for Improved Clinical Outcomes

Precision Medicine in Rheumatology: Personalizing Treatment for Improved Clinical Outcomes

By

Judith A. James, MD, PhD, discusses the developments of precision medicine in rheumatology at the 2018 State-of-the-Art Clinical Symposium.

GI Safety Compared for NSAIDs in Patients With Arthritis

GI Safety Compared for NSAIDs in Patients With Arthritis

By

The randomized, double-blind, controlled trial (N=24,081) included patients with rheumatoid arthritis or osteoarthritis who required chronic NSAID treatment.

Expert Q&A: Effects of Collaborative Care Models on Patient Satisfaction in Rheumatoid Arthritis

Expert Q&A: Effects of Collaborative Care Models on Patient Satisfaction in Rheumatoid Arthritis

By

John M. Davis III, MD, MS, from the Mayo Clinic in Rochester, Minnesota, and Jennifer Gorman, MD, MPH, from The Polyclinic in Seattle, Washington, discuss the evolving collaborative care therapy model in RA.

Certain RA Treatments Tied to Improvements in Blood Pressure

Certain RA Treatments Tied to Improvements in Blood Pressure

By

Certain disease-modifying therapies for rheumatoid arthritis may have a positive effect on blood pressure.

Biosimilar Etanercept SB4 May Decrease Disease Activity in Inflammatory Rheumatic Disease

Biosimilar Etanercept SB4 May Decrease Disease Activity in Inflammatory Rheumatic Disease

By

Nonmandatory transitioning from originator etanercept to biosimilar etanercept SB4 using a specifically designed communication strategy showed a slightly lower persistence rate and smaller decreases in disease activity.

Top-Line Results Announced for Investigational RA Treatment Upadacitinib

Top-Line Results Announced for Investigational RA Treatment Upadacitinib

By

At week 12, results showed 71% in the upadacitinib group had achieved ACR20, compared to 63% and 36% in the adalimumab and placebo groups, respectively.

Quality of Life in Rheumatoid Arthritis Improved With Filgotinib

Quality of Life in Rheumatoid Arthritis Improved With Filgotinib

By

The results of 2 randomized controlled trials showed that filgotinib improved quality of life when given in combination with methotrexate or as monotherapy in rheumatoid arthritis.

Women With SLE Become Pregnant More Easily vs Women With Rheumatoid Arthritis

Women With SLE Become Pregnant More Easily vs Women With Rheumatoid Arthritis

By

Researchers examined differences in the ability to get pregnant in women with systemic lupus erythematosus and rheumatoid arthritis.

Sign Up for Free e-newsletters